Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bluebird Bio (NQ: BLUE ) 0.6887 +0.0117 (+1.73%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bluebird Bio < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > 7 Cheap Biotech Stocks to Buy Now May 19, 2022 These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains. Via InvestorPlace Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data May 10, 2022 Via Benzinga Analyst Ratings for bluebird bio May 10, 2022 Over the past 3 months, 6 analysts have published their opinion on bluebird bio (NASDAQ:BLUE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks April 08, 2022 Cash will be king in biotech picks like BLUE stock as governments slow approvals and reimbursements of new gene therapies. Via InvestorPlace 10 Biggest Price Target Changes For Wednesday April 06, 2022 Raymond James reduced the price target on Intercontinental Exchange, Inc. (NYSE: ICE) from $161 to $157. Intercontinental Exchange shares rose 0.2% to $130.79 in pre-market trading. Via Benzinga Bluebird Bio Joins Layoff Band Wagon As Gene Therapy Biotech Cuts Staff To Reduce Costs April 05, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Friday February 04, 2022 On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... Via Benzinga Where bluebird bio Stands With Analysts January 06, 2022 Within the last quarter, bluebird bio (NASDAQ:BLUE) has observed the follow... Via Benzinga 92 Biggest Movers From Friday May 09, 2022 Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... Via Benzinga Expert Ratings For bluebird bio April 06, 2022 Within the last quarter, bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings: Via Benzinga 55 Stocks Moving In Friday's Mid-Day Session May 06, 2022 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. Via Benzinga FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials March 15, 2022 The FDA has outlined new draft guidance on what should be submitted in a clinical trial application and potentially concerning safety issues to track the genome editing products. Via Benzinga bluebird bio's Return On Capital Employed Insights March 10, 2022 According to Benzinga Pro data, during Q4, bluebird bio (NASDAQ:BLUE) posted sales of $1.61 million. Earnings were up 28.49%, but bluebird bio still reported an overall loss of $... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 April 06, 2022 Upgrades Via Benzinga Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Niu Technologies Shares Plunge March 07, 2022 U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 600 points on Monday. The Secretary of State Antony Blinken said on Sunday that the... Via Benzinga 76 Biggest Movers From Yesterday March 08, 2022 Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc... Via Benzinga Expert Ratings For bluebird bio March 07, 2022 Within the last quarter, bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... Via Benzinga Mid-Day Market Update: Nasdaq Drops 250 Points; Bed Bath & Beyond Shares Surge March 07, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq dropping 250 points on Monday. The Secretary of State Antony Blinken said on Sunday that the United States and its... Via Benzinga 46 Stocks Moving In Monday's Mid-Day Session March 07, 2022 Gainers Houston American Energy Corp. (NYSE: HUSA) jumped 137.4% to $4.5150 amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc. (NASDAQ:... Via Benzinga Why Bluebird Bio Shares Are Tumbling Today March 07, 2022 Hit by several delays for its gene therapy programs, Bluebird bio Inc (NASDAQ: BLUE) ended 2021 with a cash and equivalents balance of approximately $442 million.... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022 March 07, 2022 Upgrades According to Brookline Capital, the prior rating for Intellia Therapeutics Inc (NASDAQ:NTLA) was changed from Hold to Buy. In the fourth quarter, Intellia Therapeutics... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday March 07, 2022 Welcome back, trader! Let's get right into it with an overview of the biggest pre-market stock movers for Monday morning! Via InvestorPlace A Peek Into The Markets: US Stock Futures Tumble; Crude Oil Jumps Over 7% March 07, 2022 Pre-open movers U.S. stock futures traded lower in early pre-market trade amid escalating Russia-Ukraine concerns. Investors are awaiting earnings results from Ciena Corporation... Via Benzinga 5 Stocks To Watch - Monday, Mar. 7 March 07, 2022 Some of the stocks that may grab investor focus today. Via Talk Markets 5 Stocks To Watch For March 7, 2022 March 07, 2022 Some of the stocks that may grab investor focus today are: Wall Street expects Ciena Corporation (NYSE: CIEN) to report quarterly earnings at $0.45 per share on revenue of $856... Via Benzinga FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies January 18, 2022 The FDA has extended the review period for Bluebird bio Inc's (NASDAQ: BLUE) biologics licensing applications (BLA) for its lentiviral vector gene... Via Benzinga Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference January 11, 2022 Bluebird bio Inc (NASDAQ: BLUE) announced planned updates to be presented at the 40th Annual J.P. Morgan Healthcare conference, including 2022 program milestones and... Via Benzinga Stocks That Hit 52-Week Lows On Thursday February 17, 2022 On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session December 29, 2021 Gainers Cognition Therapeutics (NASDAQ:CGTX Via Benzinga Mid-Day Market Update: Crude Oil Drops Over 5%; Society Pass Shares Jump December 20, 2021 Midway through trading Monday, the Dow traded down 1.78% to 34,735.33 while the NASDAQ fell 1.43% to 14,952.69. The S&P also fell, dropping 1.59% to 4,547.26. The U.S. has the... Via Benzinga < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.